Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
ACB.TO

Price
5.98
Stock movement down
-0.16 (-3.29%)
Company name
Aurora Cannabis Inc
Exchange
(TO
,
Currency
CAD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
265.90M
Ent value
359.98M
Price/Sales
0.73
Price/Book
0.47
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
11.28
Forward P/E
42.73
PEG
-
EPS growth
-
1 year return (CAGR)
-50.53%
3 year return (CAGR)
-29.65%
5 year return (CAGR)
-51.50%
10 year return (CAGR)
-1.55%
Last updated: 2026-02-12

DIVIDENDS

ACB.TO does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E11.28
Price to OCF21.51
Price to FCF-
Price to EBITDA5.77
EV to EBITDA7.81

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.73
Price to Book0.47
EV to Sales0.99

FINANCIALS

Per share

Loading...
Per share data
Current share count56.58M
EPS (TTM)0.42
FCF per share (TTM)-0.75

Income statement

Loading...
Income statement data
Revenue (TTM)364.96M
Gross profit (TTM)177.47M
Operating income (TTM)-5.56M
Net income (TTM)23.57M
EPS (TTM)0.42
EPS (1y forward)0.11

Margins

Loading...
Margins data
Gross margin (TTM)48.63%
Operating margin (TTM)-1.52%
Profit margin (TTM)6.46%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash95.69M
Net receivables46.73M
Total current assets423.85M
Goodwill25.59M
Intangible assets34.98M
Property, plant and equipment0.00
Total assets756.86M
Accounts payable49.34M
Short/Current long term debt0.00
Total current liabilities124.12M
Total liabilities189.76M
Shareholder's equity567.10M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)12.36M
Capital expenditures (TTM)25.60M
Free cash flow (TTM)-41.68M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity4.16%
Return on Assets3.11%
Return on Invested Capital4.16%
Cash Return on Invested Capital-7.35%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.84
Daily high4.87
Daily low4.63
Daily Volume405K
All-time high1808.40
1y analyst estimate7.80
Beta1.24
EPS (TTM)0.42
Dividend per share0.00
Ex-div date23 Aug 2018
Next earnings date-

Downside potential

Loading...
Downside potential data
ACB.TOS&P500
Current price drop from All-time high-99.67%-0.89%
Highest price drop-99.78%-56.47%
Date of highest drop14 Mar 20249 Mar 2009
Avg drop from high-70.14%-10.86%
Avg time to new high66 days12 days
Max time to new high1840 days1805 days
COMPANY DETAILS
ACB.TO (Aurora Cannabis Inc) company logo
Marketcap
265.90M
Marketcap category
Small-cap
Description
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
Employees
0
Investor relations
-
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the company will ring the Nasdaq closing bell on Wednesday, February 18, 2026, at t...
February 12, 2026
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is expanding its Aurora® medical portfolio in Australia and New Zealand, delivering patients ...
February 11, 2026
Download the Complete Report Here By Karen Roman Our favorite plug’s strategy is paying off: Net revenue is increasing and earnings quality keeps improving. Aurora Cannabis Inc. (Nasdaq: ACB) reported...
February 9, 2026
Key Takeaways; Cannabis Sector Aurora Cannabis Announced Refocused Strategy as Global Medical Sales Hit Record High in 2026 Third Quarter Canopy Growth Reported Mixed Results in its Fiscal Third Quart...
February 8, 2026
Aurora Cannabis beat Q3 earnings and sales estimates as medical cannabis momentum drove growth, but persistent consumer weakness pressured the stock outlook.
February 6, 2026
Aurora Cannabis Inc (ACB) reports a 7% revenue increase and strong international performance, despite challenges in consumer cannabis and plant propagation segments.
February 4, 2026
Aurora Cannabis (NASDAQ:ACB) reported fiscal third-quarter 2026 results that management said reflect its long-running focus on global medical cannabis and a strategy centered on profitability and sust...
February 4, 2026
In fiscal Q3, first, net revenue increased 7%, driven by a record 12% growth in global medical cannabis revenue, including a 17% increase internationally. Notably, more than half of our total net rev...
February 4, 2026
Aurora Cannabis (NASDAQ and TSX: ACB) was at last look up 0.5% in US premarket trade on Wednesday as
February 4, 2026
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has filed a prospectus supplement establi...
February 4, 2026
Next page